So many amazing IGNITE! presentations at #AEMP26! Great job to all of the presenters! Special shout out and big congratulations to this year's 2026 IGNITE! winners, Drs. Russ Scarpa, Amberlyn Bacchuss and Allison Bushaw!
#AEMP#AEMPlify#EMRx#IGNITE!
@ZCiochettoMD424 A cidal abx has a minimum bactericidal concentration (MBC) not more than 4-fold above its MIC. A static abx has an MBC more than 4-fold above its MIC.
So then, what is the MBC?
The MBC = concentration that results in a 1,000-fold reduction in bacterial density at 24 h growth...
There have been a number of questions raised about my statement that GRADE should be abandoned as a basis for drafting clinical guidelines. It's a simple issue that can seem complex. And people have some preconceived ideas that I want to clarify in this string.
1/16
Fresh paper.
Adenosine is metabolized by red blood cells.
Do people with higher hematocrit need higher Adenosine doses?
Nope, but now we know. Negative studies matter 😂
Amazing work by our past resident Dr. Seth Carroll (@SethCPharmD)
https://t.co/VxgcJe0xiD
LAST CALL to submit your application to present an Ignite! Pharmacy Pearl at #SAEM26. Submission deadline is TODAY, January 12th! Resident submissions are welcome. https://t.co/WRgj5NIRax
#AEMP#AEMPlify#EMRx#AEMP26
LAST CALL for Ignite! Resident Pearls - submission deadline to present at #SAEM26 is next Monday, January 12th!
https://t.co/pZNE1UZDFq
#AEMP#AEMPlify#EMRx#Ignite! #AEMP26
Interested in a PGY2 pharm residency in emergency medicine? There is no better place to train than Detroit Receiving. Stop by our showcase at Midyear & chat with me about it! We are recruiting for a resident for next year. Showcase is Tues, Dec 9 1pm-4pm, booth 6041. #ashpmidyear
It’s the most wonderful time of the year 🎶
The #NACCT2025 abstracts are here!
>300 abstracts of pure unfettered toxicology research published in @Clin_Tox
I never finish reading without 10+ research ideas and having my jaw drop twice
https://t.co/MITj4e7kbe
The 2025 AHA/ACC Hypertension Guidelines are out, and the changes are significant. Here are the key takeaways for pharmacists & clinicians:
"Hypertensive Urgency" is now "Severe Hypertension" for BP >180/120 w/o target organ damage.
Move away from IV meds for asymptomatic severe HTN. Oral initiation is key.
New, specific BP targets for ICH & post-reperfusion ischemic stroke.
The PREVENT risk calculator is in, setting new thresholds (≥7.5% risk) for starting meds at BP ≥130/80.
Swipe through the carousel for a full visual breakdown of these practice-changing updates!
🚨 NEW POD ALERT 🚨
🎃October 2024 EM Clinical Pearls🚑
Esmolol in Refractory VF/VT with Mallory McGee @mallorymcgee17
Fomepizole with Seth Carroll @SethCPharmD
Sugammadex in the ED with Cecilia Schowe @ceciliaschowe